MELISSA MARTZ: Open Payments
NPI 1558724393 · GREENACRES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 10 payments from 6 companies in 2025. Trend: 2023 $337 · 2024 $54 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $95 |
| UCB, Inc. | 1 | $38 |
| Lilly USA, LLC | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
Products named: AUSTEDO XR, Rystiggo, RELISTOR, XTAMPZA, BOTOX, AMYVID, MOUNJARO.
Industry payments across FL — which companies pay providers there.
